Q1 2020 FibroGen Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the FibroGen First Quarter 2020 Financial Results. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Mr. Michael Tung. Please go ahead, sir.
Thank you, operator, and good afternoon, everyone. Thank you for joining us on today's call to discuss FibroGen's results for the first quarter of 2020.
Today's call will be led by Enrique Conterno, our Chief Executive Officer. Enrique will be joined by Dr. Peony Yu, our Chief Medical Officer; Ms. Chris Chung, our Senior Vice President of China Operations; Dr. Elias Kouchakji, our Senior Vice President of Clinical Development, Drug Safety and Pharmacovigilance; and Mr. Pat Cotroneo, our Chief Financial Officer.
Before we begin, I would like to point out that we may make forward-looking statements regarding our business, including our collaborations with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |